Williams S P, Durbin G M, Morgan M E, Booth I W
Birmingham Maternity Hospital.
Arch Dis Child Fetal Neonatal Ed. 1995 Nov;73(3):F158-61. doi: 10.1136/fn.73.3.f158.
To test the hypothesis that relative pancreatic dysfunction is a determinant of catch up growth in small for gestational age (SGA) babies, 47 such babies (median gestation 38 weeks; range 27-41) and 41 appropriate for gestational age (AGA) babies matched for sex, race, and gestational age were recruited. Anthropometry was performed within 48 hours of birth and at 6 months. Faecal chymotrypsin activities were measured at 0-2 days, 14 days, 6 weeks and 6 months. At 6 months 30 SGA infants and 25 AGA infants were remeasured. In each group, median stool chymotrypsin activities doubled between 0-2 days and 6 months (9.0-25.5 IU/g SGA group; 11.6-25.3 IU/g AGA group). SGA babies had significantly lower chymotrypsin activities at 14 days (10.9 U/g) than AGA babies (15.5 U/g). In the SGA group faecal chymotrypsin activities at 0-2 days were strongly correlated with both catch up weight and with catch up length when corrected for the effects of birthweight. These data show that impaired pancreatic exocrine function at birth is associated with severe intrauterine malnutrition and with impaired catch up growth during the first 6 months of life.
为验证相对胰腺功能障碍是小于胎龄(SGA)儿追赶生长的决定因素这一假说,招募了47例此类婴儿(中位孕周38周;范围27 - 41周)以及41例性别、种族和孕周匹配的适于胎龄(AGA)儿。在出生后48小时内及6个月时进行人体测量。在0 - 2天、14天、6周和6个月时测量粪便糜蛋白酶活性。在6个月时,对30例SGA婴儿和25例AGA婴儿进行了重新测量。每组中,粪便糜蛋白酶活性中位数在0 - 2天至6个月之间翻倍(SGA组为9.0 - 25.5 IU/g;AGA组为11.6 - 25.3 IU/g)。SGA婴儿在14天时的糜蛋白酶活性(10.9 U/g)显著低于AGA婴儿(15.5 U/g)。在SGA组中,校正出生体重影响后,0 - 2天的粪便糜蛋白酶活性与追赶体重及追赶身长均密切相关。这些数据表明,出生时胰腺外分泌功能受损与严重宫内营养不良以及出生后前6个月追赶生长受损有关。